Literature DB >> 34095838

Hormone-like conopeptides - new tools for pharmaceutical design.

Ashlin Turner1, Quentin Kaas1, David J Craik1.   

Abstract

Conopeptides are a diverse family of peptides found in the venoms of marine cone snails and are used in prey capture and host defence. Because of their potent activity on a range of mammalian targets they have attracted interest as leads in drug design. Until recently most focus had been on studying conopeptides having activity at ion channels and related neurological targets but, with recent discoveries that some conopeptides might play hormonal roles, a new area of conopeptide research has opened. In this article we first summarize the canonical pharmaceutical families of Conus venom peptides and then focus on new research relating to hormone-like conopeptides and their potential applications. Finally, we briefly examine methods of chemically stabilizing conopeptides to improve their pharmacological properties. A summary is presented of conopeptides in clinical trials and a call for future work on hormone-like conopeptides. This journal is © The Royal Society of Chemistry.

Entities:  

Year:  2020        PMID: 34095838      PMCID: PMC8126879          DOI: 10.1039/d0md00173b

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  131 in total

Review 1.  Ion channel toxins and therapeutics: from cone snail venoms to ciguatera.

Authors:  R J Lewis
Journal:  Ther Drug Monit       Date:  2000-02       Impact factor: 3.681

2.  A vasopressin/oxytocin-related conopeptide with gamma-carboxyglutamate at position 8.

Authors:  Carolina Möller; Frank Marí
Journal:  Biochem J       Date:  2007-06-15       Impact factor: 3.857

3.  Total synthesis of the analgesic conotoxin MrVIB through selenocysteine-assisted folding.

Authors:  Aline Dantas de Araujo; Brid Callaghan; Simon T Nevin; Norelle L Daly; David J Craik; Melissa Moretta; Gene Hopping; Macdonald J Christie; David J Adams; Paul F Alewood
Journal:  Angew Chem Int Ed Engl       Date:  2011-05-31       Impact factor: 15.336

4.  Molecular identification of a Drosophila G protein-coupled receptor specific for crustacean cardioactive peptide.

Authors:  Giuseppe Cazzamali; Frank Hauser; Sune Kobberup; Michael Williamson; Cornelis J P Grimmelikhuijzen
Journal:  Biochem Biophys Res Commun       Date:  2003-03-28       Impact factor: 3.575

5.  Interactions of disulfide-deficient selenocysteine analogs of μ-conotoxin BuIIIB with the α-subunit of the voltage-gated sodium channel subtype 1.3.

Authors:  Brad R Green; Min-Min Zhang; Sandeep Chhabra; Samuel D Robinson; Michael J Wilson; Addison Redding; Baldomero M Olivera; Doju Yoshikami; Grzegorz Bulaj; Raymond S Norton
Journal:  FEBS J       Date:  2014-06-09       Impact factor: 5.542

6.  Insect cardioactive peptides: cardioacceleratory peptide (CAP) activity is blocked in vivo and in vitro with a monoclonal antibody.

Authors:  N J Tublitz; P D Evans
Journal:  J Neurosci       Date:  1986-08       Impact factor: 6.167

7.  Efficient enzymatic cyclization of an inhibitory cystine knot-containing peptide.

Authors:  Soohyun Kwon; Frank Bosmans; Quentin Kaas; Olivier Cheneval; Anne C Conibear; K Johan Rosengren; Conan K Wang; Christina I Schroeder; David J Craik
Journal:  Biotechnol Bioeng       Date:  2016-08-09       Impact factor: 4.530

8.  Evolution of glycoprotein hormone subunit genes in bilateral metazoa: identification of two novel human glycoprotein hormone subunit family genes, GPA2 and GPB5.

Authors:  Sheau Yu Hsu; Koji Nakabayashi; Alka Bhalla
Journal:  Mol Endocrinol       Date:  2002-07

Review 9.  Conotoxins that confer therapeutic possibilities.

Authors:  Magbubah Essack; Vladimir B Bajic; John A C Archer
Journal:  Mar Drugs       Date:  2012-06-04       Impact factor: 6.085

Review 10.  Neuronal and Extraneuronal Nicotinic Acetylcholine Receptors.

Authors:  Michele Zoli; Susanna Pucci; Antonietta Vilella; Cecilia Gotti
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

View more
  1 in total

Review 1.  Peptidylglycine α-amidating monooxygenase as a therapeutic target or biomarker for human diseases.

Authors:  David J Merkler; Aidan J Hawley; Betty A Eipper; Richard E Mains
Journal:  Br J Pharmacol       Date:  2022-02-28       Impact factor: 9.473

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.